GPX4 and colorectal carcinoma: Notably, in ESSENCE knockdown tumors (CRC xenograft mouse model in Fig. 3H), there was a concurrent decrease in the expression of GPX4 and SLC7A11 as demonstrated by immunohistochemistry staining (Fig. 6E).